Plain-English translation of NCT07389733 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This trial is testing a new medication called HRS-6208 paired with other drugs to see if it can help people with advanced breast cancer that has spread or cannot be removed by surgery. Researchers want to understand how safe the medication is, what side effects it causes, and whether it actually helps slow or stop the cancer from growing. You would be assigned to receive the medication as part of one of three different treatment combinations.
Advanced breast cancer that has spread to other parts of the body or cannot be surgically removed is difficult to treat, and current treatments don't work well enough for everyone. This trial exists to see whether this new medication, used in combination with other drugs, could offer patients a more effective option.
You likely qualify if…
You likely don't qualify if…
You will visit the study center regularly to receive your assigned medication combination and have your blood drawn and health checked. You will be in one of three treatment groups, each receiving the new medication paired with a different existing or experimental drug. The study will monitor how your body responds to the treatment, track any side effects, and measure whether your cancer is responding. Your participation will continue as long as the treatment is helping and you are tolerating it well.
AI-generated summary from trial data · Jun 24, 2026 · Not medical advice
China